Novozymes AS (NVZMY)
Company Info
Highlights
$26.60B
$0.98
57.20
0.23
$13.66B
$5.72B
$2.25B
$53.89 - $72.19
$74.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Novozymes AS, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Novozymes AS had a return of -1.06% year-to-date (YTD) and 1.24% in the last 12 months. Over the past 10 years, Novozymes AS had an annualized return of 2.72%, while the S&P 500 had an annualized return of 11.26%, indicating that Novozymes AS did not perform as well as the benchmark.
NVZMY
-1.06%
-2.17%
-15.52%
1.24%
2.28%
2.72%
^GSPC (Benchmark)
4.01%
1.13%
9.82%
22.80%
12.93%
11.26%
Monthly Returns
The table below presents the monthly returns of NVZMY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.68% | -1.06% | |||||||||||
| 2024 | -6.10% | 9.32% | 3.94% | -5.04% | 7.30% | 2.97% | 3.96% | 9.10% | 4.40% | -13.36% | -6.33% | -3.37% | 3.94% |
| 2023 | 2.59% | -6.71% | 7.84% | 1.70% | -7.67% | -3.08% | 7.99% | -13.58% | -7.01% | 12.58% | 15.90% | 5.82% | 12.56% |
| 2022 | -16.93% | -3.69% | 6.84% | 1.20% | -9.62% | -5.45% | 6.18% | -9.51% | -12.26% | 4.05% | 8.15% | -11.11% | -37.67% |
| 2021 | 4.97% | 3.07% | 4.66% | 11.00% | 2.43% | 3.25% | 4.19% | 2.83% | -15.09% | 7.34% | 2.21% | 9.17% | 44.87% |
| 2020 | 6.56% | -1.90% | -9.82% | 7.70% | 11.63% | 5.69% | 3.68% | -1.04% | 6.24% | -4.61% | -4.56% | 0.17% | 19.08% |
| 2019 | -6.16% | 10.51% | 1.26% | 1.18% | 0.82% | -0.52% | 0.02% | -8.53% | -1.58% | 12.02% | 1.50% | 2.42% | 11.73% |
| 2018 | -2.65% | -7.29% | 1.30% | -8.29% | 7.69% | -0.35% | 3.88% | 4.26% | -0.03% | -9.99% | -5.75% | -4.35% | -20.96% |
| 2017 | 12.87% | 0.46% | 3.03% | 8.65% | 4.91% | -3.56% | 5.27% | 10.42% | 1.04% | 7.61% | -1.84% | 5.46% | 68.02% |
| 2016 | -13.83% | 4.83% | 4.79% | 6.46% | -0.72% | 0.28% | 2.86% | -11.81% | 1.62% | -15.69% | -8.58% | 1.87% | -27.39% |
| 2015 | 8.04% | 6.61% | -5.10% | 1.09% | 3.88% | -1.04% | 10.54% | -17.16% | 0.05% | 7.02% | 3.17% | 0.13% | 15.06% |
| 2014 | 2.08% | 8.93% | -5.49% | 8.82% | 2.20% | 2.51% | -1.23% | -6.05% | -6.75% | 6.87% | -5.02% | -4.15% | 0.85% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of NVZMY is 50, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Novozymes AS (NVZMY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Novozymes AS provided a 1.05% dividend yield over the last twelve months, with an annual payout of $0.59 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.59 | $0.59 | $1.47 | $0.85 | $0.85 | $0.78 | $0.76 | $0.74 | $0.57 | $0.51 | $0.45 | $0.46 |
Dividend yield | 1.05% | 1.04% | 2.68% | 1.67% | 1.03% | 1.35% | 1.55% | 1.66% | 1.00% | 1.48% | 0.93% | 1.09% |
Monthly Dividends
The table displays the monthly dividend distributions for Novozymes AS. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | ||||||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.59 |
| 2023 | $0.00 | $0.00 | $0.88 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $1.47 |
| 2022 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 |
| 2021 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 |
| 2020 | $0.00 | $0.78 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.78 |
| 2019 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.76 |
| 2018 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.74 |
| 2017 | $0.00 | $0.57 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.57 |
| 2016 | $0.00 | $0.51 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.51 |
| 2015 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 |
| 2014 | $0.46 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.46 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Novozymes AS. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Novozymes AS was 57.08%, occurring on Oct 27, 2008. Recovery took 350 trading sessions.
The current Novozymes AS drawdown is 27.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -57.08% | Aug 9, 2007 | 243 | Oct 27, 2008 | 350 | Jul 27, 2010 | 593 |
| -51.05% | Jan 3, 2022 | 439 | Oct 2, 2023 | — | — | — |
| -39.48% | Aug 5, 2015 | 340 | Dec 8, 2016 | 196 | Sep 21, 2017 | 536 |
| -31.43% | Jun 7, 2011 | 291 | Aug 2, 2012 | 125 | Feb 5, 2013 | 416 |
| -28.47% | Jan 8, 2018 | 413 | Aug 28, 2019 | 192 | Jun 3, 2020 | 605 |
Volatility
Volatility Chart
The current Novozymes AS volatility is 6.68%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Novozymes AS compared to its peers in the Specialty Chemicals industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for NVZMY in comparison to other companies of the Specialty Chemicals industry. Currently, NVZMY has a PE value of 57.2. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for NVZMY in comparison to other companies of the Specialty Chemicals industry. Currently, NVZMY has a PEG value of 0.2. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Novozymes AS.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |